CI Investments Inc’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-24
Closed -$3K 1124
2021
Q1
$3K Buy
24
+8
+50% +$946 ﹤0.01% 999
2020
Q4
$2K Buy
16
+8
+100% +$929 ﹤0.01% 955
2020
Q3
$1K Buy
+8
New +$859 ﹤0.01% 927
2016
Q3
Sell
-65,700
Closed -$6.99M 233
2016
Q2
$6.99M Buy
65,700
+7,600
+13% +$883K 0.08% 130
2016
Q1
$6.65M Buy
58,100
+2,500
+4% +$293K 0.08% 121
2015
Q4
$7.92M Buy
55,600
+10,300
+23% +$1.19M 0.1% 115
2015
Q3
$4.07M Buy
45,300
+2,500
+6% +$264K 0.05% 133
2015
Q2
$4.93M Buy
42,800
+10,200
+31% +$1.07M 0.05% 140
2015
Q1
$3.11M Buy
+32,600
New +$2.44M 0.03% 140

CI Investments Inc's CBPO Position: Q2 2021 in Review

CI Investments Inc sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 24 shares — an estimated $3K sold.

CI Investments Inc first reported a position in CBPO in Q1 2015 and held it in 9 quarters. The position peaked at $7.92M in Q4 2015. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • CI Investments Inc reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
  • CI Investments Inc sold 24 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $3K.
  • CI Investments Inc first reported a position in China Biologic Products Holdings, Inc. in Q1 2015 and held it in 9 quarters.
  • CI Investments Inc's China Biologic Products Holdings, Inc. position peaked at $7.92M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on CI Investments Inc's 13F filing for Q2 2021, filed 13 Aug 2021.